Some areas of AAO.org are temporarily unavailable. We apologize for the inconvenience and are working to restore access.

  • Alimera Sciences
    Comprehensive Ophthalmology

    Alimera Sciences reported a net loss of $14.8 million for the fourth quarter of 2013, compared with a loss of $5.3 million for the fourth quarter of 2012.

    The company attributed this result to an increase in the fair value of its derivative warrant liability, a non-cash unrealized foreign currency gain, and inventory problems.

    For all of 2013 Alimera posted a $51.2 million loss, compared with a loss of $19.8 million in 2012.

    Net revenue increased slightly for the fourth quarter of 2013, to $935,000, compared to the fourth quarter of 2012.